Verminoside from Pseudolysimachion rotundum var. subintegrum sensitizes cisplatin-resistant cancer cells and suppresses metastatic growth of human breast cancer
Abstract Breast cancer is one of the most common cancers in women and is associated with a high mortality rate. The majority of deaths resulting from breast cancer are attributable to metastatic growth; in addition, chemoresistance is a major concern in the treatment of patients with breast cancer....
Guardado en:
Autores principales: | Changhu Lee, Hyung Won Ryu, Sahee Kim, Min Kim, Sei-Ryang Oh, Kyung-Seop Ahn, Jiyoung Park |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4c04b9f1f738472281baa399332239d9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cisplatin improves antitumor activity of weekly nab-paclitaxel in patients with metastatic breast cancer
por: Sun S, et al.
Publicado: (2014) -
Olaparib modulates DNA repair efficiency, sensitizes cervical cancer cells to cisplatin and exhibits anti-metastatic property
por: Chandra Bhushan Prasad, et al.
Publicado: (2017) -
Genomic landscape of extraordinary responses in metastatic breast cancer
por: Sun Min Lim, et al.
Publicado: (2021) -
Autophagy in Cisplatin Nephrotoxicity during Cancer Therapy
por: Xiaoru Hu, et al.
Publicado: (2021) -
Phase II trial of cisplatin, gemcitabine and pembrolizumab for platinum-resistant ovarian cancer.
por: Christine S Walsh, et al.
Publicado: (2021)